Oncology Institute (TOI) Operating Leases (2022 - 2026)

Oncology Institute has reported Operating Leases for 5 years, with the latest figure at $18.8 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 12.75% year-over-year to $18.8 million; the trailing twelve-month figure through Mar 2026 stood at $18.8 million (down 12.75% YoY), and the FY2025 full-year result was $19.1 million, down 17.62% from the prior year.
• Operating Leases for Q1 2026 stood at $18.8 million, down from $19.1 million in the prior quarter.
• The five-year high for Operating Leases was $32.6 million in Q2 2023, with the low at $14.6 million in Q2 2022.
• Historically, Operating Leases has averaged $23.6 million across 5 years, with a median of $22.1 million in 2022.
• Annual changes were most pronounced in 2023 — Operating Leases surged 123.4% — and 2025, when it slumped 35.71%.
• Oncology Institute's Operating Leases stood at $22.1 million in 2022, then rose by 20.06% to $26.5 million in 2023, then dropped by 12.32% to $23.2 million in 2024, then dropped by 17.62% to $19.1 million in 2025, then slipped by 1.51% to $18.8 million in 2026.
• The last three Operating Leases figures came in at $18.8 million (Q1 2026), $19.1 million (Q4 2025), and $20.2 million (Q3 2025), per Business Quant data.